Loading...
XSHG600613
Market cap493mUSD
Jan 09, Last price  
6.81CNY
1D
-2.71%
1Q
17.21%
Jan 2017
-51.46%
Name

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd

Chart & Performance

D1W1MN
XSHG:600613 chart
P/E
63.54
P/S
1.55
EPS
0.11
Div Yield, %
1.83%
Shrs. gr., 5y
-0.47%
Rev. gr., 5y
4.79%
Revenues
2.34b
-2.00%
76,150,38369,835,17762,362,02065,958,55169,622,28676,975,441105,841,382148,250,092153,999,261929,184,1501,293,713,3301,592,912,4881,597,867,9211,735,715,9551,852,905,9511,927,593,2141,819,006,6912,303,032,7192,388,617,6772,340,945,518
Net income
57m
+17.41%
15,096,2987,780,3032,891,11213,790,5354,384,43405,674,00317,554,36513,701,765111,540,028180,170,055216,730,448182,059,820129,601,273106,091,39083,974,764069,622,53748,548,12157,000,674
CFO
216m
-32.47%
4,960,95632,719,702016,007,52125,264,7037,690,62733,035,3810074,749,395030,117,673570,41366,987,417148,525,997128,279,88899,097,235184,263,469319,232,403215,590,355
Dividend
Jun 18, 20240.1 CNY/sh
Earnings
May 20, 2025

Profile

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.
URL
http://www.gzsq.com/
IPO date
Aug 20, 1992
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,340,946
-2.00%
2,388,618
3.72%
Cost of revenue
2,058,228
2,198,257
Unusual Expense (Income)
NOPBT
282,717
190,361
NOPBT Margin
12.08%
7.97%
Operating Taxes
25,149
15,219
Tax Rate
8.90%
7.99%
NOPAT
257,568
175,142
Net income
57,001
17.41%
48,548
-30.27%
Dividends
(66,292)
(53,450)
Dividend yield
1.68%
1.21%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
65,936
65,427
Long-term debt
204,161
232,669
Deferred revenue
1,530
Other long-term liabilities
1,260
Net debt
(547,885)
(438,571)
Cash flow
Cash from operating activities
215,590
319,232
CAPEX
(24,513)
Cash from investing activities
(30,409)
Cash from financing activities
(125,922)
(133,935)
FCF
287,625
364,054
Balance
Cash
736,175
656,490
Long term investments
81,807
80,176
Excess cash
700,935
617,236
Stockholders' equity
1,565,828
1,548,438
Invested Capital
1,943,957
2,005,425
ROIC
13.04%
8.32%
ROCE
10.63%
7.23%
EV
Common stock shares outstanding
518,188
538,635
Price
7.61
-7.53%
8.23
28.19%
Market cap
3,943,410
-11.04%
4,432,965
28.93%
EV
3,450,704
4,040,121
EBITDA
376,007
286,792
EV/EBITDA
9.18
14.09
Interest
16,081
17,366
Interest/NOPBT
5.69%
9.12%